Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.46 HKD
2.21 B HKD
14.62 B HKD
2.42 B
About SHANDONG WEIGAO GROUP MEDICAL
Sector
Industry
CEO
Rinan Cong
Website
Headquarters
Weihai
Founded
1988
ISIN
CNE100000171
FIGI
BBG000LFJVD9
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1066 is 4.57 HKD — it has decreased by −0.44% in the past 24 hours. Watch SHANDONG WEIGAO GROUP MEDICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANDONG WEIGAO GROUP MEDICAL stocks are traded under the ticker 1066.
1066 stock has fallen by −9.15% compared to the previous week, the month change is a 2.47% rise, over the last year SHANDONG WEIGAO GROUP MEDICAL has showed a −37.57% decrease.
We've gathered analysts' opinions on SHANDONG WEIGAO GROUP MEDICAL future price: according to them, 1066 price has a max estimate of 7.27 HKD and a min estimate of 6.37 HKD. Watch 1066 chart and read a more detailed SHANDONG WEIGAO GROUP MEDICAL stock forecast: see what analysts think of SHANDONG WEIGAO GROUP MEDICAL and suggest that you do with its stocks.
1066 reached its all-time high on Aug 6, 2020 with the price of 22.70 HKD, and its all-time low was 3.60 HKD and was reached on Jul 2, 2024. View more price dynamics on 1066 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1066 stock is 2.42% volatile and has beta coefficient of 1.31. Track SHANDONG WEIGAO GROUP MEDICAL stock price on the chart and check out the list of the most volatile stocks — is SHANDONG WEIGAO GROUP MEDICAL there?
Today SHANDONG WEIGAO GROUP MEDICAL has the market capitalization of 21.44 B, it has increased by 2.07% over the last week.
Yes, you can track SHANDONG WEIGAO GROUP MEDICAL financials in yearly and quarterly reports right on TradingView.
SHANDONG WEIGAO GROUP MEDICAL is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
1066 earnings for the last half-year are 0.27 HKD per share, whereas the estimation was 0.26 HKD, resulting in a 4.17% surprise. The estimated earnings for the next half-year are 0.25 HKD per share. See more details about SHANDONG WEIGAO GROUP MEDICAL earnings.
SHANDONG WEIGAO GROUP MEDICAL revenue for the last half-year amounts to 7.13 B HKD, despite the estimated figure of 7.34 B HKD. In the next half-year revenue is expected to reach 7.39 B HKD.
1066 net income for the last half-year is 1.20 B HKD, while the previous report showed 868.74 M HKD of net income which accounts for 38.15% change. Track more SHANDONG WEIGAO GROUP MEDICAL financial stats to get the full picture.
SHANDONG WEIGAO GROUP MEDICAL dividend yield was 2.41% in 2023, and payout ratio reached 37.40%. The year before the numbers were 1.43% and 25.65% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 12.52 K employees. See our rating of the largest employees — is SHANDONG WEIGAO GROUP MEDICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANDONG WEIGAO GROUP MEDICAL EBITDA is 3.27 B HKD, and current EBITDA margin is 23.93%. See more stats in SHANDONG WEIGAO GROUP MEDICAL financial statements.
Like other stocks, 1066 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANDONG WEIGAO GROUP MEDICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANDONG WEIGAO GROUP MEDICAL technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANDONG WEIGAO GROUP MEDICAL stock shows the sell signal. See more of SHANDONG WEIGAO GROUP MEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.